Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX): DMC Approves Phase III Study Of Firdapse
Boston, MA 10/22/2013 (wallstreetpr) – After the Data Monitoring Committee (DMC) approval, Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) will now continue with the pivotal phase III clinical trial […]